Safety and Preliminary Efficacy Findings from a Phase 2A Randomized, Double-Blind, Placebo-Controlled Trial of Setanaxib in Patients with Alport Syndrome SA-OR082
![[jpg]](/themes/Mirage2/images/thumbnails/mimes/jpg.png "jpg")
Identificadores
URI: https://hdl.handle.net/10481/109150Exportar
Metadatos
Mostrar el registro completo del ítem
Excepto si se señala otra cosa, la licencia del ítem se describe como Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License